[Home ] [Archive]    
:: Current Issue :: Search :: Send Article ::
Main Menu
Home
Journal Information
About SJMS
Aims & Scopes
Editorial Board
Indexing & Abstracting
Articles archive
All Issues
Current Issue
For Authors
Authors Guide
Reference Guide
Authorship Criteria
Submit an Article
For Reviewers
Principle of Transparency
Publication Ethics Statement
Research Ethics Statement
Open Access Statement
Peer-Review Process
Governing Body
Publication Fees
Research Misconducts
Conflicts of Interests
Financial Policies
Publishing/Archiving Policies
Ownership and Management
Copyright
Contact us
::
:: Volume 1, Issue 3 (2022) ::
Sci J Iranshahr Univ Med Sci 2022, 1(3): 143-148 Back to browse issues page
New Polycystic Ovary Syndrome in Gynecology
S. Ghalandari1, Sh. Zolala1 , S. Dadshahi * 2
1- "Nursing Research Center" and ” Razi Faculty of Nursing and Midwifery", Kerman University of Medical Sciences, Kerman, Iran
2- "Nursing Research Center”, “Counselling in Midwifery Department, Razi Faculty of Nursing and Midwifery", Kerman University of Medical Sciences, Kerman, Iran , sahebeh68.dadshahi@gmail.com
Abstract:   (205 Views)
Aims: Polycystic ovarian syndrome is a highly prevalent disorder. The worldwide prevalence of polycystic ovarian syndrome ranges from 4% to 21%. Depression and anxiety are more common and more severe in women with polycystic ovarian syndrome than in women without the disorder. This study aimed to systematically review the literature for polycystic ovarian syndrome.
Information & Methods: A systematic search of EMBASE, Cochrane, PubMed, CINAHL, Google Scholar, Scopus, and International Pharmaceutical Abstracts from inception until January 2019 utilizing the terms polycystic ovarian syndrome was conducted.
Findings: Polycystic ovarian syndrome and insulin resistance share a common genetic background. Metabolic dysfunction can exist among people even when controlling for BMI and body fat distribution. Obesity is common in women with polycystic ovarian syndrome and exacerbates metabolic stress. Infertility was noted by 72% of women reporting polycystic ovarian syndrome. Depression and anxiety are more common and more severe in women with polycystic ovarian syndrome. Cardiovascular disease markers point to a higher risk of Cardiovascular disease in women with polycystic ovarian syndrome. Obstructive sleep apnea is common in clinical samples of women with polycystic ovarian syndrome.
Conclusion: A complication of polycystic ovary syndrome is insulin resistance, metabolic dysfunction, obesity, Infertility, cardiovascular disease, obstructive sleep apnea, Depression, and anxiety.
 
Keywords: Polycystic Ovary Syndrome, Midwives, Gynecologists.
Full-Text [PDF 1117 kb]   (507 Downloads)    
Article Type: Systematic Review/Meta Analysis | Subject: Reproductive Medicine
Received: 2021/08/15 | Accepted: 2022/01/15 | Published: 2022/03/30
* Corresponding Author Address: Kerman University of Medical Sciences, Kerman, Iran. Postal Code: 7616913555
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghalandari S, Zolala S, Dadshahi S. New Polycystic Ovary Syndrome in Gynecology. Sci J Iranshahr Univ Med Sci 2022; 1 (3) :143-148
URL: http://sjiums.irshums.ac.ir/article-1-20-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 1, Issue 3 (2022) Back to browse issues page
مجله علمی علوم پزشکی Scientific Journal of Medical Sciences
Persian site map - English site map - Created in 0.06 seconds with 38 queries by YEKTAWEB 4645